Search Articles :
Re-size text: Decrease Text Size Increase Text Size

Cancer Specialist Joins Stephenson Cancer Center

Monday, October 24, 2016 - Campus News -

Vipul G. Pareek, M.D., a hematologist-oncologist, has established his medical practice with the Stephenson Cancer Center. He has also been named an assistant professor of hematology-oncology at the University of Oklahoma College of Medicine. 

Pareek is board certified in internal medicine and board eligible in hematology-oncology. He specializes in the care of patients with cancers of the lung, esophagus and soft tissues. 

Pareek completed a hematology-oncology fellowship at Montefiore Medical Center/Albert Einstein College of Medicine, New York City. He completed his internal medicine residency at St. Luke’s and Roosevelt Hospital, New York City. He finished his medical school in India and also did a residency in nuclear medicine prior to coming to the United States.

He is a member of the American Society of Hematology, American Society of Clinical Oncology and American College of Physicians. 

Pareek sees patients at the Stephenson Cancer Center, 800 N.E. 10th St. For an appointment, call (405) 271-8299. 

Oklahoma’s only comprehensive academic cancer center, the Stephenson Cancer Center at the University of Oklahoma is a nationally noted leader in research and patient care. The Stephenson Cancer Center annually ranks among the top three cancer centers in the nation for patients participating in National Cancer Institute-sponsored treatment trials, and it is one of 30 designated lead centers nationally in the Institute’s National Clinical Trials Network. In collaboration with the Oklahoma Tobacco Settlement Endowment Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 250 research members who are conducting more than 215 cancer research projects at institutions across Oklahoma. This research is supported by $48.3 million in annual funding from the National Cancer Institute, the American Cancer Society and other sponsors.

Related Articles:

No Related Content Found

Related Materials